JPS59137421A - Preparation of physiologically active substance - Google Patents

Preparation of physiologically active substance

Info

Publication number
JPS59137421A
JPS59137421A JP58011404A JP1140483A JPS59137421A JP S59137421 A JPS59137421 A JP S59137421A JP 58011404 A JP58011404 A JP 58011404A JP 1140483 A JP1140483 A JP 1140483A JP S59137421 A JPS59137421 A JP S59137421A
Authority
JP
Japan
Prior art keywords
active
ethanol
active substance
physiologically active
tank
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP58011404A
Other languages
Japanese (ja)
Other versions
JPH0434526B2 (en
Inventor
Akiji Yano
矢野 明次
Toshiyuki Kosugi
小杉 敏行
Koichi Mutsukawa
六川 功一
Kazuyoshi Okubo
一良 大久保
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NAGANOKEN KOORIDOUFU KOGYO KYODO KUMIAI
NAGANOKEN MISO KOGYO KYODO KUMIAI
Original Assignee
NAGANOKEN KOORIDOUFU KOGYO KYODO KUMIAI
NAGANOKEN MISO KOGYO KYODO KUMIAI
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NAGANOKEN KOORIDOUFU KOGYO KYODO KUMIAI, NAGANOKEN MISO KOGYO KYODO KUMIAI filed Critical NAGANOKEN KOORIDOUFU KOGYO KYODO KUMIAI
Priority to JP58011404A priority Critical patent/JPS59137421A/en
Publication of JPS59137421A publication Critical patent/JPS59137421A/en
Publication of JPH0434526B2 publication Critical patent/JPH0434526B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

PURPOSE:To obtain a physiologically active substance having anticholesteric and antilipemic activities, etc., such as saponin, flavonoid, etc., easily from the boiled soup, juice and whey produced from the preparation process of soybean foods, by the absorption and desorption of the substance using charcoal, active carbon, etc. CONSTITUTION:A physiologically active substance composed mainly of saponin, flavonoid and its glycoside is separated from the boiled soup, juice, and whey of soybeans, by the adsorption and desorption using charcoal, active coal and active resin. For example, the boiled soup, juice, etc. are transferred from the waste liquid tank 1 to the recovery column 3 packed with active coal to effect the adsorption of the physiologically active substance. Thereafter, ethanol is supplied from the ethanol tank 2 to the recovery column 3 to desorb the active fraction, which is distilled by the ethanol distillation apparatus 4. The residue is taken out of the apparatus 4 through the outlet 13, and dried to obtain the objective active substance. The active substance can be adsorbed easily with active coal, etc., and desorbed easily with ethanol. The active coal, etc. can be reused without causing lowering of adsorptivity.

Description

【発明の詳細な説明】 本発明は、煮豆、味噌、醤油、納豆、凍豆腐、豆腐およ
び分離蛋白の製造工程で生じ、廃液として捨てられてい
る「煮汁」、「ゆ」あるいは「ホエー」から、抗コレス
テロール作用、抗脂血作用および脂肪代謝の促進に関与
するサポニン、フラボノイド、イソフラボノイドおよび
その配糖体を主体とする生理活性物質を、木炭、活性炭
あるいは活性樹脂の吸脱着により取得する生理活性物質
の製造法に関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention is a method for producing boiled beans, miso, soy sauce, natto, frozen tofu, tofu, and isolated protein from the "broth,""yu," or "whey" produced in the manufacturing process and discarded as waste liquid. Physiologically active substances, mainly saponins, flavonoids, isoflavonoids, and their glycosides, which are involved in anticholesterolemic effects, antilipemic effects, and promotion of fat metabolism, are obtained by adsorption and desorption of charcoal, activated carbon, or activated resin. Concerning methods of manufacturing substances.

食生活の欧米化に伴なう過剰栄養障害(肥満、高血圧、
脳溢血、動脈硬化などの心臓性疾患、糖尿病、癌等)が
現れ始めていることがら、植物性食品の効用が注目され
始めている。この植物性食6^の効用のうち、特に大豆
食“品においては、サポニンおよびインフラボンの抗酸
化作用、抗脂血作用、抗コレステロール作用および脂質
代謝促進作用に基ついていることが最近明らかとなって
おり(大久保−良、曽根清秀「大豆を中心としたサポニ
ンの食品栄養学的児直し」食品開発Vo1.6 。
Overnutrition disorders (obesity, high blood pressure,
As symptoms of cerebral hemorrhage, heart diseases such as arteriosclerosis, diabetes, cancer, etc. are beginning to appear, the benefits of plant foods are beginning to attract attention. It has recently become clear that the effects of plant foods, especially soybean foods, are based on the antioxidant, antilipemic, anticholesterolemic, and lipid metabolism promoting effects of saponins and inflavones. (Ryo Okubo, Kiyohide Sone, "Food nutritional rejuvenation using saponins centered on soybeans," Food Development Vol. 1.6.

765.1981、大久保−良、高橋勝美「大豆配糖体
成分の化学と生理作用」食品開発Vol。17゜A、7
 、1982 ) 、本発明者らの本発明に到達す4過
程で、未確認配糖体成分にも基づいていることを明らか
にすることができた。したがって、その生理作用をもつ
補助食品素材の開発が急務とされてきた。
765.1981, Ryo Okubo, Katsumi Takahashi "Chemistry and physiological effects of soybean glycoside components" Food Development Vol. 17°A, 7
, 1982), the present inventors were able to clarify that the present invention was also based on an unidentified glycoside component. Therefore, there has been an urgent need to develop supplementary food materials that have these physiological effects.

本発明により得られる生理活性物質は、大豆のサポニン
、インフラボノイド、フラボノイドおよびその配糖体の
混合物質で、抗酸化、抗コレステロール、抗脂血および
脂質代謝促進のいずれの作用なももっていることが、以
下に述べる本発明者らの詳細な研究から明らかになった
The physiologically active substance obtained by the present invention is a mixture of soybean saponins, infravonoids, flavonoids, and their glycosides, and has antioxidant, anticholesterol, antilipidemic, and lipid metabolism promoting effects. This has become clear from detailed research by the present inventors described below.

煮豆、味噌、醤油、納豆、木綿豆腐、凍豆腐および分離
蛋白の製造工程で生じる「煮汁」、「ゆ」および「ホエ
ー」は無価値なものとみなされ、むしろ公害の恐れがあ
るために、余分の経費と規模の大きいラグーンないし活
性汚泥方式の施設で処理され、河川に捨てられている。
The ``broth,''``yu,'' and ``whey'' generated in the manufacturing process of boiled beans, miso, soy sauce, natto, firm tofu, frozen tofu, and protein isolate are considered to be worthless, and rather, they are not used in excess because they pose a risk of pollution. The waste is treated in expensive and large-scale lagoons or activated sludge facilities, and then disposed of into rivers.

「煮汁」、「ゆ」および「ホエー」についての研究は皆
無に等しく、本発明者らは、公害の恐れのあるこれら廃
液の原因物質に注目し、詳細にその研究を行ない、以下
に示すとおりの結果を得た。すなわち、「煮汁」、「ゆ
」および「ホエー」を濃縮乾固し、下記に示す操作で粗
サポニンと粗インフラホン配糖体区分を得た。
There is almost no research on "boiled soup", "yu" and "whey", and the present inventors focused on the causative substances of these waste liquids, which may cause pollution, and conducted detailed research, as shown below. The results were obtained. That is, the "broth", "yu" and "whey" were concentrated to dryness, and crude saponin and crude inflavone glycoside fractions were obtained by the operations shown below.

試料 ]了シタノールによる還流抽出 メタノール抽出液 ブタノール層 沈臥     上澄 粗サポニン区分の収量は、粗インフラボン配糖体区分の
1/100程度で非常に少なかった。これらを薄層クロ
マトグラフィーで検討した結果、収量の少ない粗サポニ
ン区分に明らかにサポニン相当のバンドが検出され、粗
インフラボン区分では、「煮汁」、「ゆ」およびI−ホ
エー」共にゲニステインが圧倒的に多く、続いてゲニス
チン、グリシディン配糖体、グイジン、ダイジエイン、
グリシティンが検出され、未確認配糖体成分が数多く検
出をれた。前記薄層クロマトグラフィーを第1図に示し
た。
Sample] Reflux extraction with citanol, methanol extract, butanol layer settling The yield of the supernatant crude saponin fraction was very small, about 1/100 of the crude inflavone glycoside fraction. As a result of examining these by thin-layer chromatography, a band corresponding to saponin was clearly detected in the crude saponin category, which has a low yield, and in the crude inflavone category, genistein was overwhelmingly present in "boiled soup,""yu," and I-whey. followed by genistin, glycidin glycoside, guidine, daidiene,
Glycitin was detected, and many unidentified glycoside components were detected. The thin layer chromatography is shown in FIG.

次に、この粗サポニン区分と粗イソフラボン区分および
対照としての生理的食塩水をラットに投与して飼育後、
解剖所見、計重量、血中コレステロール、トリグリセラ
イド、遊離脂肪酸、GOTおよびGPTの測定を行なっ
た。その結果、第2図G)(ロ)(ハ)に示すように、
生理的食塩水投与群に対して、粗サポニン投与群では僅
かな血中トリグリセライドの低下と幾分高い計重量とG
OTであったが、総じて著しい投与の効果がみられなか
った。
Next, this crude saponin fraction, crude isoflavone fraction, and physiological saline as a control were administered to rats, and after rearing,
Anatomical findings, weight, blood cholesterol, triglyceride, free fatty acids, GOT and GPT were measured. As a result, as shown in Figure 2G)(B)(C),
Compared to the physiological saline administration group, the crude saponin administration group had a slight decrease in blood triglyceride and a somewhat higher measured weight and G.
Although it was OT, no significant effects of administration were observed overall.

これに対して粗イソフラボン区分投与群では、血中コレ
ステロール、トリグリセライド、GOT。
In contrast, in the crude isoflavone group, blood cholesterol, triglyceride, and GOT were significantly reduced.

GPTのいずれも著しく低下し、明らかな抗コレステロ
ール作用、抗脂血作用および抗肝機能障害作用が認めら
れた。
GPT levels were all significantly reduced, and clear anticholesterolemic, antilipidemic, and antihepatic dysfunction effects were observed.

そこで、1−煮汁」、「ゆ」および「ホエー」からの粗
イソフラボン区分に相当する生理活性区分の簡便な回収
法全検討した結果、粗イソフシボン区分に相当する成分
のいずれも、活性炭、木炭、活性樹脂に容易に吸着し、
エタノールで容易に脱着することがわかった。しかも、
その吸着量は、活性炭、木炭、活性樹脂の重量の5〜1
0チにも相幽し、脱着後の活性炭等は、再度吸着能の低
下刃しに繰り返し使用できることもわかった。よシ詳糺
に「ゆ」からの回収例で説明すると、廃液IゆJf:逃
した粒状活性炭1 kgから各濃度のエタノール水浴液
で脱着した結果、第3図に示すように、10%、60%
、80%エタノール部分にピークのみられる脱着挙動が
現れている。さらにこれらの脱着区分をTLCで調べた
結果(第4図)、60〜80%に僅かのサポニンが検出
されたが、全般にインフラボン類が多く、90%エタノ
ールではソ完全に脱着することがわかった。したがって
、90〜100%エタノールで生理活性のある全ての成
分を脱着することができる。
Therefore, as a result of all studies on simple recovery methods for physiologically active fractions corresponding to the crude isoflavones from ``1-broth'', ``yu'' and ``whey'', we found that none of the components corresponding to the crude isoflavones were active carbon, charcoal, charcoal, Easily adsorbs to active resin,
It was found that it was easily desorbed with ethanol. Moreover,
The adsorption amount is 5 to 1 of the weight of activated carbon, charcoal, and activated resin.
It was also found that activated carbon, etc., after desorption can be used repeatedly to reduce adsorption capacity. To explain in detail using an example of recovery from "YU", waste liquid IYJf: As a result of desorption from 1 kg of escaped granular activated carbon with an ethanol water bath solution of various concentrations, as shown in Figure 3, 10%, 60%
, a desorption behavior with a peak seen in the 80% ethanol portion appears. Furthermore, as a result of examining these desorption sections by TLC (Figure 4), a small amount of saponin was detected in 60 to 80%, but in general, infravones were present, and 90% ethanol was not able to completely desorb them. Understood. Therefore, all physiologically active components can be desorbed with 90-100% ethanol.

以上の結果に基づいた廃液からの活性標品の製造法を、
第5図に示す工程説明図にしたがって説明する。第5図
において、(1)は廃液タンク、(2)はエタノールタ
ンク、(3)は回収槽、(4)はエタノール蒸溜装置、
(5)は廃液処理施設であり、(6)は廃液タンク(1
)と回収槽(3)を連結する管、(7)はエタノールタ
ンク(2)の底部と管(6)を三方弁(8)で連結する
管、(9)は回収槽(3)と廃液処理施設(5)を連結
する管、00)はエタノール蒸溜装置(4)の底部と管
(9)を三方弁0])で連結する管、a2)はエタノー
ル蒸溜装置(4)の上部とエタノールタンク(2)の上
部を連結する管、α3)はエタノール蒸溜装置(4)の
底部に設けた取出管である。まず、回収@(3)に活性
炭、木炭あるいは活性樹脂を充填し、この回収槽(3)
に廃液タンク(1)から廃液である「煮汁」、「ゆ」あ
るいは「ホエー」を送り、活性成分を吸着させる。吸着
後、エタノールタンク(2)から回収槽(3)にエタノ
ールを送り、活性区分を脱着させてエタノール蒸溜装置
(4)に送り、腰部してエタノールをエタノールタンク
(2)に決し、腰部残基は取出管α3)から取シ出し、
乾燥して活性標品を得る。
Based on the above results, we developed a method for producing active preparations from waste liquid.
The process will be explained according to the process diagram shown in FIG. In Figure 5, (1) is a waste liquid tank, (2) is an ethanol tank, (3) is a recovery tank, (4) is an ethanol distillation device,
(5) is the waste liquid treatment facility, and (6) is the waste liquid tank (1
) and the collection tank (3), (7) is the pipe that connects the bottom of the ethanol tank (2) and the pipe (6) with a three-way valve (8), and (9) is the pipe that connects the collection tank (3) and the waste liquid. A pipe connecting the processing facility (5), 00) is a pipe connecting the bottom of the ethanol distillation device (4) and the pipe (9) with a three-way valve 0]), and a2) is a pipe connecting the top of the ethanol distillation device (4) to the ethanol distillation device (4). A pipe connecting the upper part of the tank (2), α3), is a take-out pipe provided at the bottom of the ethanol distillation device (4). First, the recovery tank (3) is filled with activated carbon, charcoal, or activated resin.
A waste liquid such as "broth", "yu" or "whey" is sent from the waste liquid tank (1) to the liquid waste tank (1), and the active ingredients are adsorbed. After adsorption, ethanol is sent from the ethanol tank (2) to the recovery tank (3), the active fraction is desorbed and sent to the ethanol distillation device (4), and the ethanol is transferred to the ethanol tank (2), where the active fraction is desorbed and the ethanol is transferred to the ethanol tank (2). Take it out from the take-out pipe α3),
Dry to obtain active preparation.

次に、本発明の実施例を挙げて説明する。Next, examples of the present invention will be described.

実施例1 第5図の回収槽には、8kgの活性炭金水20.4に懸
濁させた吸着剤24.5tが詰められている。
Example 1 The collection tank shown in FIG. 5 is filled with 24.5 tons of adsorbent suspended in 8 kg of activated carbon and 20.4 tons of gold water.

豆腐工場からの廃液「ゆ」1トン全回収槽に流し込み、
20%エタノール水で洗った後、60〜95%エタノー
ル751−を流して吸着物質を溶出した。この溶出液を
減圧濃縮しぞ濃縮物と回収エタノールを得た。この濃縮
物を凍結ないし噴霧乾燥して第1目標品4082を得た
。さらに回収槽’150tの水で洗った後、再び廃液「
ゆ」1トンを流し、同様の操作で第2目標品4022を
得た。
Pour 1 ton of waste liquid from the tofu factory into a recovery tank.
After washing with 20% ethanol water, the adsorbed substances were eluted by flowing 60-95% ethanol 751-. This eluate was concentrated under reduced pressure to obtain a concentrate and recovered ethanol. This concentrate was frozen or spray dried to obtain the first target product 4082. After washing with 150 tons of water from the recovery tank, the waste liquid is
A second target product 4022 was obtained using the same procedure.

以上の操作を計5回繰り返し、その収量は第6回407
7、第4回698グ、第5回4051で、吸着能力の低
下はみられず、半永久的に回収槽を使用することができ
た。得られた生理活性標品を分析した結果、6?チのイ
ソフラボノイド系成分と8%のザボニン系成分からなり
、インフラボノイド系成分の主成分はゲニスティンであ
った。なお、20%エタノール溶出液と水洗液からもエ
タノールを回収して再使用することができる。
Repeat the above operation 5 times in total, and the yield is 407 for the 6th time.
7. In the 4th test at 698g and the 5th test at 4051, no decrease in adsorption capacity was observed, and the recovery tank could be used semi-permanently. As a result of analyzing the obtained physiologically active specimen, 6? It consisted of isoflavonoid components of chi and 8% of zabonin components, and the main infravonoid component was genistein. Note that ethanol can also be recovered and reused from the 20% ethanol eluate and the water washing solution.

以上の操作で活性炭の代りに木炭を用いた場合にも、木
炭をあらかじめ粗砕して活性炭同様に回収槽に詰め、活
性炭の場合と全く同様の操作で第1回3722、第2回
6762、第3回6611、第4回6707、第5回6
787の標品を得ることができた。
Even when charcoal is used instead of activated carbon in the above operation, the charcoal is crushed in advance and packed into a recovery tank in the same way as activated carbon, and the first 3722, second 6762, 3rd 6611, 4th 6707, 5th 6
I was able to obtain a standard specimen of 787.

実施例2 弱塩基性陰イオン交換樹脂AGIX4,5tを第5図の
回収槽に詰め、豆腐工場からの洗液「ゆ」1トンを回収
槽に流し込み、6〜4N酢酸IQtで洗った後、5〜1
ON酢酸20tで吸右物質を溶出した。この溶出液を減
圧濃縮して濃縮物と回収酢酸を得、さらに濃縮物を凍結
ないし噴霧乾燥して第1目標品3067を得た。続いて
回収槽を40tの水で洗った後、再び廃液「ゆ」1トン
を流し込み、同様の操作で第2目標品294グ全イセた
。以上の操作全針5回繰り返し、その収量は第6回27
07、第4回2562、第5回2482で、吸着能力の
幾分の低下がみられたが、樹脂を塩酸で活性化しなおす
ことにより、半永久的に使用することができた。得られ
た生理活性標品を分析した結果、81%のインフラボノ
イド系成分と12係のザボニン系成分からなり、インフ
ラボノイド系成分の主成分はゲニステインであった。な
お、6〜4N酢酸溶出液と水洗液からも酢酸を回収17
て再便用することができる。
Example 2 Weakly basic anion exchange resin AGIX4.5t was packed in the recovery tank shown in Figure 5, 1 ton of washing liquid "YU" from the tofu factory was poured into the recovery tank, and after washing with 6-4N acetic acid IQt, 5-1
The adsorption substance was eluted with 20 tons of ON acetic acid. This eluate was concentrated under reduced pressure to obtain a concentrate and recovered acetic acid, and the concentrate was further frozen or spray-dried to obtain the first target product 3067. Subsequently, after washing the recovery tank with 40 tons of water, 1 ton of waste liquid "YU" was poured into it again, and all 294 grams of the second target product were recovered in the same manner. Repeat the above operation 5 times for all needles, and the yield is 6th 27th
07, 4th 2562 and 5th 2482, some decrease in adsorption capacity was observed, but by reactivating the resin with hydrochloric acid, it was possible to use it semi-permanently. As a result of analysis of the obtained physiologically active preparation, it was found that it consisted of 81% infravonoid components and 12 zabonin components, and the main component of the infravonoid components was genistein. In addition, acetic acid was also recovered from the 6-4N acetic acid eluate and the water washing solution17.
It can be reused.

シロ 方重 例 6 実施例1の方法に準じて、大豆の照汁、酸沈澱タンパク
賃調製[祐の大豆ホエー、そして、大豆の水U、、液〃
・らヤれそれ生理活性標品を得た。その供試数量、収量
、およびザポニンとインフラボノイド系成分の含量を表
1に示した。
Example 6 According to the method of Example 1, soybean broth, acid precipitated protein preparation [soybean whey, soybean water U, liquid]
・We obtained a physiologically active specimen. Table 1 shows the sample quantity, yield, and content of zaponin and infravonoid components.

表   1 実施例4 実施例2の方法に準じて、大豆の煮汁、酸沈澱タンパク
質調製時の大豆ホエー、そして、大豆の水洗液からそれ
ぞれ生理活性標品を得た。その供試液量、収量、および
サポニンとイソフラボノイド系成分の含量を表2に示し
た。
Table 1 Example 4 According to the method of Example 2, physiologically active samples were obtained from soybean broth, soybean whey used in acid-precipitated protein preparation, and soybean washing liquid. Table 2 shows the amount of sample solution, yield, and content of saponin and isoflavonoid components.

表  2Table 2

【図面の簡単な説明】[Brief explanation of the drawing]

第1図は粗サポニンと粗イソフラボン区分の薄層クロマ
トグラフィー、第2図(イ)(ロ)(ハ)は計重量、血
中コレステロール、トリグリセライド、遊離脂肪酸、G
OTおよびGPTに及ぼす粗サポニンと粗インフラボン
投与の影響を示す図表、第3図は1kgの吸着活性炭か
らのエタノールによる脱着結果を示すグラフ、第4図は
1kgの吸着活性炭からのエタノールによる脱着活性区
分の薄層クロマトグラフィー、第5図は本発明の工程説
明図である。 代理人 清 水   猛、7:″、。 −5−2二−ソ 隼、5め (わ 千4]
Figure 1 is thin layer chromatography of crude saponin and crude isoflavones, Figure 2 (a), (b), and (c) are measured weights, blood cholesterol, triglycerides, free fatty acids, and G.
A graph showing the effects of crude saponin and crude inflavone administration on OT and GPT. Figure 3 is a graph showing the desorption results of ethanol from 1 kg of adsorbed activated carbon. Figure 4 shows the desorption activity of ethanol from 1 kg of adsorbed activated carbon. Sectional thin layer chromatography, FIG. 5 is a diagram illustrating the process of the present invention. Agent Takeshi Shimizu, 7:″. -5-2 2-So Hayabusa, 5th (Wasen 4)

Claims (1)

【特許請求の範囲】[Claims] 煮豆、味噌、醤油、納豆の製造に際して生じる「煮汁」
、豆腐の製造に際して生じる「ゆ」あるいは分離蛋白の
製造に際して生じる「ホエー」から、サポニン、フジボ
ッイド、インフラボノイドおよびその配糖体を主体とす
る生理活性物質を、木炭、活性炭あるいは活性樹脂の吸
脱着により取得することを特徴とする生理活性物質の製
造法。
The "broth" produced during the production of boiled beans, miso, soy sauce, and natto
, physiologically active substances, mainly saponins, fujiboids, infravonoids, and their glycosides, are absorbed from the "yu" produced during the production of tofu or the "whey" produced during the production of isolated proteins by adsorption and desorption of charcoal, activated carbon, or activated resin. A method for producing a physiologically active substance, characterized in that it is obtained by.
JP58011404A 1983-01-28 1983-01-28 Preparation of physiologically active substance Granted JPS59137421A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP58011404A JPS59137421A (en) 1983-01-28 1983-01-28 Preparation of physiologically active substance

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58011404A JPS59137421A (en) 1983-01-28 1983-01-28 Preparation of physiologically active substance

Publications (2)

Publication Number Publication Date
JPS59137421A true JPS59137421A (en) 1984-08-07
JPH0434526B2 JPH0434526B2 (en) 1992-06-08

Family

ID=11777077

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58011404A Granted JPS59137421A (en) 1983-01-28 1983-01-28 Preparation of physiologically active substance

Country Status (1)

Country Link
JP (1) JPS59137421A (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6153218A (en) * 1984-08-23 1986-03-17 Rikagaku Kenkyusho Hypertensive preventive
WO1997037549A1 (en) * 1996-04-10 1997-10-16 Nichimo Co., Ltd. Substance containing health-promoting component and process for the production thereof
US5855892A (en) * 1997-09-19 1999-01-05 Potter; Susan M. Method for decreasing LDL-cholesterol concentration and increasing HDL-cholesterol concentration in the blood to reduce the risk of atherosclerosis and vascular disease
US6132795A (en) * 1998-03-15 2000-10-17 Protein Technologies International, Inc. Vegetable protein composition containing an isoflavone depleted vegetable protein material with an isoflavone containing material
US6479054B1 (en) 1998-09-21 2002-11-12 Showa Sangyo Co., Ltd. Process for obtaining genistin-rich isoflavone composition
US6544566B1 (en) 1999-04-23 2003-04-08 Protein Technologies International, Inc. Composition containing plant sterol, soy protein and isoflavone for reducing LDL cholesterol
US7285297B1 (en) 1999-04-23 2007-10-23 Archer-Daniels-Midland Company Method of reducing low density liproprotein cholesterol concentration
JP2008173090A (en) * 2007-01-22 2008-07-31 Izutsu Miso:Kk Manufacturing method of "miso" (fermented soybean paste)
JP2008546845A (en) * 2005-06-28 2008-12-25 ケージーケー シナガイズ インク. Compositions that improve the bioavailability of polymethoxyflavones and tocotrienols for the treatment of cardiovascular disease

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52151712A (en) * 1976-06-03 1977-12-16 Inverni Della Beffa Spa Composition for medical preparation
JPS5910520A (en) * 1982-07-08 1984-01-20 Kikkoman Corp Production of soybean saponin

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52151712A (en) * 1976-06-03 1977-12-16 Inverni Della Beffa Spa Composition for medical preparation
JPS5910520A (en) * 1982-07-08 1984-01-20 Kikkoman Corp Production of soybean saponin

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6153218A (en) * 1984-08-23 1986-03-17 Rikagaku Kenkyusho Hypertensive preventive
JPH0364486B2 (en) * 1984-08-23 1991-10-07 Rikagaku Kenkyusho
WO1997037549A1 (en) * 1996-04-10 1997-10-16 Nichimo Co., Ltd. Substance containing health-promoting component and process for the production thereof
US5855892A (en) * 1997-09-19 1999-01-05 Potter; Susan M. Method for decreasing LDL-cholesterol concentration and increasing HDL-cholesterol concentration in the blood to reduce the risk of atherosclerosis and vascular disease
US6132795A (en) * 1998-03-15 2000-10-17 Protein Technologies International, Inc. Vegetable protein composition containing an isoflavone depleted vegetable protein material with an isoflavone containing material
US6479054B1 (en) 1998-09-21 2002-11-12 Showa Sangyo Co., Ltd. Process for obtaining genistin-rich isoflavone composition
US6544566B1 (en) 1999-04-23 2003-04-08 Protein Technologies International, Inc. Composition containing plant sterol, soy protein and isoflavone for reducing LDL cholesterol
US6572876B2 (en) 1999-04-23 2003-06-03 Solae, Llc Administering a composition containing plant sterol, soy protein and isoflavone for reducing LDL-cholesterol
US6579534B2 (en) 1999-04-23 2003-06-17 Solae, Llc Composition containing soy hypocotyl material and plant sterol for reducing LDL-cholesterol
US6669952B2 (en) 1999-04-23 2003-12-30 Solae, Llc Composition containing isoflavone material and plant sterol for reducing LDL-cholesterol
US7285297B1 (en) 1999-04-23 2007-10-23 Archer-Daniels-Midland Company Method of reducing low density liproprotein cholesterol concentration
JP2008546845A (en) * 2005-06-28 2008-12-25 ケージーケー シナガイズ インク. Compositions that improve the bioavailability of polymethoxyflavones and tocotrienols for the treatment of cardiovascular disease
JP2008173090A (en) * 2007-01-22 2008-07-31 Izutsu Miso:Kk Manufacturing method of "miso" (fermented soybean paste)

Also Published As

Publication number Publication date
JPH0434526B2 (en) 1992-06-08

Similar Documents

Publication Publication Date Title
EP2212004B1 (en) Method to recover bioactive compounds
Güçlü-Üstündağ et al. Pressurized low polarity water extraction of saponins from cow cockle seed
CN101485705A (en) Cooked Panax notoginseng and cooked Panax notoginseng standard extract and application thereof
JPS59137421A (en) Preparation of physiologically active substance
CN100439319C (en) Method for preparing salviol acid A
CN101214253B (en) Application of anemarrhenasaponin B-II in preparing antidepressant product
KR101052574B1 (en) Method for preparing an extract fraction with enhanced ginsenosides Rg1 or Rb1 from ginseng
JPH0347049A (en) Food material from waste solution 'yu' of bean-curd and preparation of health drink
CN109796511B (en) Novel iridoid compound and preparation method and medical application thereof
CN110563584A (en) method for extracting and purifying chlorogenic acid in chrysanthemum morifolium ramat
CN112125894B (en) Method for green and efficient extraction of red clover isoflavone by using natural deep eutectic solvent
CN1456559A (en) Method for extracting soybean isoflavone
CN107468746A (en) A kind of method that middle extraction polyphenol and flavones are spent from Zhu Ying
CN103404844A (en) Composition capable of enhancing stability of lycopene and having function of relieving physical fatigue and preparation method thereof
KR20010016220A (en) Separation and Purification Method of the Isoflavon as Bioactive Material from the Soybean Embryo
JP2005139150A (en) Estrogenic agent, method for producing the same, prophylactic agent for osteoporosis and food and beverage
CN1456558A (en) Method for extracting soybean isoflavone
CN110015959A (en) A method of efficiently separating purifying caffeoyl quinic acid isomers from mulberry leaf
CN115304651B (en) Method for extracting acteoside from paulownia leaves
Yusupova et al. Technologies for Producing Drugs and Biologically Active Additives Based on Ecdysteroids from Plants Rhaponticum Carthamoides, Silene Praemixta, and Ajuga Turkestanica
JPH05500903A (en) How to remove cholesterol from dairy products
CN116693589A (en) Ergosterol compound and preparation method and application thereof
CN105175259B (en) Mulberry monomer compounds, preparation method and application thereof
CN118221516A (en) Method for extracting alpha-linolenic acid and linoleic acid from platycladi seed medicinal material
CN114652786A (en) A herba Dinophorae Bungeanae extract and method for separating eugenol from herba Dinophorae Bungeanae extract